Strs Ohio Sells 118,543 Shares of CVS Health Corporation $CVS

Strs Ohio trimmed its position in shares of CVS Health Corporation (NYSE:CVS) by 13.4% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 769,277 shares of the pharmacy operator’s stock after selling 118,543 shares during the quarter. Strs Ohio’s holdings in CVS Health were worth $55,249,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. Norges Bank bought a new position in CVS Health during the fourth quarter worth about $1,666,265,000. Wellington Management Group LLP increased its holdings in shares of CVS Health by 193.2% in the fourth quarter. Wellington Management Group LLP now owns 18,564,392 shares of the pharmacy operator’s stock worth $1,473,270,000 after acquiring an additional 12,233,675 shares in the last quarter. Amundi raised its position in shares of CVS Health by 95.3% during the third quarter. Amundi now owns 7,453,980 shares of the pharmacy operator’s stock worth $572,665,000 after purchasing an additional 3,637,943 shares during the period. Capital Research Global Investors lifted its holdings in shares of CVS Health by 24.5% during the 3rd quarter. Capital Research Global Investors now owns 11,469,250 shares of the pharmacy operator’s stock valued at $864,667,000 after purchasing an additional 2,253,531 shares in the last quarter. Finally, Arrowstreet Capital Limited Partnership lifted its holdings in shares of CVS Health by 70.5% during the 3rd quarter. Arrowstreet Capital Limited Partnership now owns 5,294,134 shares of the pharmacy operator’s stock valued at $399,125,000 after purchasing an additional 2,188,307 shares in the last quarter. Institutional investors and hedge funds own 80.66% of the company’s stock.

CVS Health Stock Down 0.1%

CVS Health stock opened at $104.74 on Friday. The company has a current ratio of 0.87, a quick ratio of 0.66 and a debt-to-equity ratio of 0.78. CVS Health Corporation has a 1-year low of $58.50 and a 1-year high of $106.15. The company has a fifty day simple moving average of $93.99 and a 200 day simple moving average of $83.13. The company has a market cap of $133.64 billion, a P/E ratio of 46.14, a price-to-earnings-growth ratio of 1.03 and a beta of 0.61.

CVS Health (NYSE:CVS) last issued its quarterly earnings results on Wednesday, May 6th. The pharmacy operator reported $2.57 EPS for the quarter, topping the consensus estimate of $2.21 by $0.36. CVS Health had a net margin of 0.72% and a return on equity of 11.88%. The firm had revenue of $100.43 billion for the quarter, compared to analysts’ expectations of $94.99 billion. During the same period in the previous year, the firm posted $2.25 EPS. The company’s revenue for the quarter was up 6.2% on a year-over-year basis. CVS Health has set its FY 2026 guidance at 7.300-7.500 EPS. Research analysts anticipate that CVS Health Corporation will post 7.44 earnings per share for the current fiscal year.

More CVS Health News

Here are the key news stories impacting CVS Health this week:

• Positive Sentiment: Analysts continue to highlight CVS Health’s strong history of earnings beats and say the company has a good setup to potentially top estimates again in its next report, which can support sentiment ahead of results. Will CVS Health (CVS) Beat Estimates Again in Its Next Earnings Report?
• Positive Sentiment: CVS Health is expanding its public-health profile through America250 community events, menopause and preventive-care initiatives, and support for Medicare obesity drug access, reinforcing its role as a broader healthcare services provider. CVS Health (CVS) Takes A Leading Role In America250 Community Health Events
• Positive Sentiment: The CVS Health Foundation announced a $1 million investment in Rhode Island nonprofits focused on health care, food, housing, and essential services, which may help brand reputation and community ties. CVS Health Foundation Invests $1 Million in Rhode Island Nonprofits Tackling Community Health Needs
• Positive Sentiment: Coverage around Medicare obesity drug coverage notes CVS and Walmart are helping seniors navigate the new benefit, highlighting CVS’s value in Medicare-related patient support. Healthy Returns: Walmart, CVS step in to help seniors navigate Medicare coverage of obesity drugs
• Neutral Sentiment: Some commentary says CVS stock may already be fully valued, with strong returns and rich earnings limiting upside if fundamentals do not accelerate further. CVS Health (CVS) Stock Looks Fully Valued With Strong Returns And Rich Earnings
• Neutral Sentiment: CVS leadership and the company’s data-and-analytics expertise remain in the spotlight, including a board appointment at Choice Hotels, but this is unlikely to materially move the stock. Choice Hotels International Appoints Artificial Intelligence Leader Ali Keshavarz to Board of Directors
• Negative Sentiment: A nationwide recall of CVS Health hemorrhoidal wipes is a modest headline risk that could weigh on sentiment due to product quality and consumer safety concerns. CVS Health hemorrhoidal wipes sold nationwide recalled
• Negative Sentiment: New reports that CVS, along with other major insurers, denied post-hospital care at high rates could increase regulatory and reputational pressure on its insurance operations and PBM/Caremark business. UnitedHealth, Humana, CVS Denied Post-Hospital Care At Some Of The Highest Rates
• Negative Sentiment: Investors are also watching fresh scrutiny of CVS Health’s Caremark pharmacy benefit manager operations, which could add uncertainty despite the company’s upbeat earnings outlook. How Investors Are Reacting To CVS Health (CVS) Earnings Optimism Amid New PBM Scrutiny and Care Initiatives

Insider Activity

In other CVS Health news, EVP Tilak Mandadi sold 69,551 shares of the business’s stock in a transaction that occurred on Friday, May 8th. The stock was sold at an average price of $89.58, for a total transaction of $6,230,378.58. Following the transaction, the executive vice president owned 10,133 shares of the company’s stock, valued at $907,714.14. The trade was a 87.28% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Larry Robbins sold 370,462 shares of the company’s stock in a transaction that occurred on Thursday, May 21st. The stock was sold at an average price of $93.45, for a total value of $34,619,673.90. Following the sale, the director owned 4,824,799 shares in the company, valued at approximately $450,877,466.55. This represents a 7.13% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 3,441,551 shares of company stock worth $323,703,977 in the last quarter. 0.85% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

CVS has been the subject of a number of research reports. Weiss Ratings reissued a “hold (c)” rating on shares of CVS Health in a research note on Friday, May 8th. Wall Street Zen cut shares of CVS Health from a “buy” rating to a “hold” rating in a report on Monday. Bank of America raised their price objective on shares of CVS Health from $100.00 to $110.00 and gave the stock a “buy” rating in a report on Monday, June 22nd. Sanford C. Bernstein upped their target price on shares of CVS Health from $94.00 to $106.00 and gave the stock an “outperform” rating in a research note on Tuesday, May 12th. Finally, UBS Group lifted their price target on CVS Health from $100.00 to $115.00 and gave the company a “buy” rating in a research note on Monday, June 8th. Twenty-one analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $101.28.

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.